| 000 | 01508 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515041732.0 | ||
| 264 | 0 | _c20061222 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGo, Aileen | |
| 245 | 0 | 0 |
_aDurable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cJun 2006 |
||
| 300 |
_a439-41 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aCentral Nervous System _xpathology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdiagnosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTomography, Emission-Computed _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Neoplasms _xdiagnosis |
| 700 | 1 | _aVenugopal, Parameswaran | |
| 700 | 1 | _aLoew, Jerome | |
| 700 | 1 | _aDjordjevic, Dragan | |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 4 _gno. 6 _gp. 439-41 |
|
| 999 |
_c16560703 _d16560703 |
||